Genmab reported DKK6M in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US USD 368M 40M
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Fresenius Medical Care FME:GR EUR 92M 7M
Genmab GEN:DC DKK 6M 0
Immunogen IMGN:US USD 867K 211K
Insmed INSM:US USD 3.35M 4K
Lonza Group LONN:SW CHF 28M 2M
Novartis NOVN:VX USD 215M 13M
Regeneron Pharmaceuticals REGN:US USD 15.3M 2.2M